应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HAE 美国血液技术
休市中 07-05 16:00:00 EDT
84.96
+0.83
+0.99%
盘后
85.00
+0.04
+0.05%
16:34 EDT
最高
85.02
最低
83.86
成交量
33.65万
今开
84.08
昨收
84.13
日振幅
1.38%
总市值
43.29亿
流通市值
42.83亿
总股本
5,095万
成交额
2,844万
换手率
0.67%
流通股本
5,042万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
用药贵、用药难,罕见病患者如何与药企共寻出路? | 行业观察
36氪 · 06-11
用药贵、用药难,罕见病患者如何与药企共寻出路? | 行业观察
美国血液技术盘中异动 股价大跌5.28%报88.27美元
自选股智能写手 · 05-22
美国血液技术盘中异动 股价大跌5.28%报88.27美元
美国血液技术2024财年实现净利润1.18亿美元,同比增加2.61%
自选股智能写手 · 05-18
美国血液技术2024财年实现净利润1.18亿美元,同比增加2.61%
Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至107.00美元。
智通财经 · 05-10
Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至107.00美元。
Needham:重申Haemonetics(HAE.US)持有评级。
智通财经 · 05-10
Needham:重申Haemonetics(HAE.US)持有评级。
Haemonetics(HAE.US):2024年Q4财报实现营收3.433亿美元,前值为3.044
智通财经 · 05-09
Haemonetics(HAE.US):2024年Q4财报实现营收3.433亿美元,前值为3.044
美国血液技术盘中异动 股价大跌6.00%报87.65美元
自选股智能写手 · 05-09
美国血液技术盘中异动 股价大跌6.00%报87.65美元
Haemonetics 公司报告截至三月的季度业绩 - 收益摘要
Reuters · 05-09
Haemonetics 公司报告截至三月的季度业绩 - 收益摘要
Haemonetics Corp 预计每股收益89美分 - 财报前瞻
Reuters · 05-07
Haemonetics Corp 预计每股收益89美分 - 财报前瞻
Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。
智通财经 · 04-12
Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。
BUZZ-Haemonetics 因收购医疗设备制造商 Attune Medical 的交易而上涨
Reuters · 03-06
BUZZ-Haemonetics 因收购医疗设备制造商 Attune Medical 的交易而上涨
百度健康上线罕见病中心,法布雷病及HAE患者可开展线上自筛
美通社 · 02-29
百度健康上线罕见病中心,法布雷病及HAE患者可开展线上自筛
更新版 1-KalVista 在遗传病后期试验中达到主要目标
Reuters · 02-13
更新版 1-KalVista 在遗传病后期试验中达到主要目标
美国血液技术盘中异动 股价大跌5.02%报74.19美元
自选股智能写手 · 02-10
美国血液技术盘中异动 股价大跌5.02%报74.19美元
美国血液技术盘中异动 快速拉升5.39%
自选股智能写手 · 02-08
美国血液技术盘中异动 快速拉升5.39%
Haemonetics Corp 预计每股收益94美分 - 财报前瞻
Reuters · 02-06
Haemonetics Corp 预计每股收益94美分 - 财报前瞻
公司概况
公司名称:
美国血液技术
所属市场:
NYSE
上市日期:
--
主营业务:
Haemonetics Corporation成立于1971年,是一个全球性医疗设备公司,致力于为客户提供创新的血液管理解决方案——血浆来源收集者,采血机构和医院,在输血行业医疗设备系统方面有着强大的品牌优势,为客户提供解决方案的同时还提供信息技术平台和增值服务,其解决方案帮助患者改善临床结果,并提高血液中的供应链效率。
发行价格:
--
{"stockData":{"symbol":"HAE","market":"US","secType":"STK","nameCN":"美国血液技术","latestPrice":84.96,"timestamp":1720209600000,"preClose":84.13,"halted":0,"volume":336478,"hourTrading":{"tag":"盘后","latestPrice":85,"preClose":84.96,"latestTime":"16:34 EDT","volume":31442,"amount":2686371.26,"timestamp":1720211682148},"delay":0,"floatShares":50417473,"shares":50953098,"eps":2.29,"marketStatus":"休市中","marketStatusCode":7,"change":0.83,"latestTime":"07-05 16:00:00 EDT","open":84.08,"high":85.02,"low":83.86,"amount":28439467.13234,"amplitude":0.013788,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.29,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720425600000},"adr":0,"listingDate":673761600000,"adjPreClose":84.13,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":84.46,"preClose":84.13,"latestTime":"08:55 EDT","volume":18067,"amount":1503582.7142,"timestamp":1720184106555},"postHourTrading":{"tag":"盘后","latestPrice":85,"preClose":84.96,"latestTime":"16:34 EDT","volume":31442,"amount":2686371.26,"timestamp":1720211682148},"volumeRatio":0.5042591971420616,"impliedVol":0.3883,"impliedVolPercentile":0.496},"requestUrl":"/m/hq/s/HAE/wiki","defaultTab":"wiki","newsList":[{"id":"2442485336","title":"用药贵、用药难,罕见病患者如何与药企共寻出路? | 行业观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2442485336","media":"36氪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442485336?lang=zh_cn&edition=full","pubTime":"2024-06-11 13:52","pubTimestamp":1718085127,"startTime":"0","endTime":"0","summary":"文 | 常泽昱编辑 | 海若镜“如果连最终用药的患者到底需要什么都不知道,那么我们提供的可能都是我们想象的服务、是患者不需要的服务。”6月上旬由蔻德罕见病中心发起的行业案例研讨会上,谈及罕见病领域药物研发中“患者洞察”的重要性,百济神州创新业务拓展及全渠道营销总监杜珊珊总结道。罕见病患者的需求,核心在于“...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240611A04H4I00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240611A04H4I00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1141","LU1169590202.USD","LU1169589451.USD","IE00B64QTZ34.USD","HAE","BK1583","BK4198","BK1576","03347"],"gpt_icon":0},{"id":"2437295149","title":"美国血液技术盘中异动 股价大跌5.28%报88.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437295149","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437295149?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:31","pubTimestamp":1716384703,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时31分,美国血液技术股票出现波动,股价快速下挫5.28%。截至发稿,该股报88.27美元/股,成交量1.5808万股,换手率0.03%,振幅1.43%。美国血液技术股票所在的医疗设备行业中,整体涨幅为0.08%。美国血液技术公司简介:美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案,改善患者护理,降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213143aef11767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213143aef11767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE","BK4198","IE00B64QTZ34.USD","LU1169590202.USD","LU1169589451.USD"],"gpt_icon":0},{"id":"2436794500","title":"美国血液技术2024财年实现净利润1.18亿美元,同比增加2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436794500","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436794500?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:22","pubTimestamp":1715962951,"startTime":"0","endTime":"0","summary":"3月31日,美国血液技术公布财报,公告显示公司2024财年净利润为1.18亿美元,同比增加2.61%;其中营业收入为13.09亿美元,同比增加11.98%,每股基本收益为2.32美元。从资产负债表来看,美国血液技术总负债12.36亿美元,其中短期债务10.23百万美元,资产负债比为1.78,流动比率为2.57。机构评级:截至2024年3月31日,当前有6家机构对美国血液技术目标价做出预测,其中目标均价为113.50美元,其中最低目标价为94.00美元,最高目标价为125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180022428b131b94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180022428b131b94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE"],"gpt_icon":0},{"id":"2434868084","title":"Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至107.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434868084","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434868084?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:45","pubTimestamp":1715352314,"startTime":"0","endTime":"0","summary":"Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至107.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102245158af163e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102245158af163e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE"],"gpt_icon":0},{"id":"2434836481","title":"Needham:重申Haemonetics(HAE.US)持有评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434836481","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434836481?lang=zh_cn&edition=full","pubTime":"2024-05-10 17:56","pubTimestamp":1715334990,"startTime":"0","endTime":"0","summary":"Needham:重申Haemonetics(HAE.US)持有评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101756348af09cde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101756348af09cde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE"],"gpt_icon":0},{"id":"2434113370","title":"Haemonetics(HAE.US):2024年Q4财报实现营收3.433亿美元,前值为3.044","url":"https://stock-news.laohu8.com/highlight/detail?id=2434113370","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434113370?lang=zh_cn&edition=full","pubTime":"2024-05-09 22:35","pubTimestamp":1715265330,"startTime":"0","endTime":"0","summary":"Haemonetics(HAE.US):2024年Q4财报实现营收3.433亿美元,前值为3.044亿美元,预期值为3.291亿美元;每股收益为0.90美元,前值为0.77美元,预期值为0.89美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092247148aed3ada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092247148aed3ada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE"],"gpt_icon":0},{"id":"2434090794","title":"美国血液技术盘中异动 股价大跌6.00%报87.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434090794","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434090794?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:32","pubTimestamp":1715261575,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时32分,美国血液技术股票出现异动,股价急速跳水6.00%。截至发稿,该股报87.65美元/股,成交量5406股,换手率0.01%,振幅1.55%。美国血液技术股票所在的医疗设备行业中,整体涨幅为0.34%。消息层面,截至21时32分,《Form 144 | 美国血液技术高管拟出售2,305股股份,价值约21.9万美元》资讯为影响美国血液技术的重要信息。关联方在任何三个月期间出售的股票数量超过5,000股时,或总市值超5万美元时须向SEC提交该表格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921325687e50ecc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921325687e50ecc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169589451.USD","BK4198","LU1169590202.USD","HAE","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2434099326","title":"Haemonetics 公司报告截至三月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434099326","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434099326?lang=zh_cn&edition=full","pubTime":"2024-05-09 19:53","pubTimestamp":1715255590,"startTime":"0","endTime":"0","summary":" * Haemonetics Corp 公布的截至3月底的季度调整后每股收益为90美分,高于去年同期的每股收益77美分。七位分析师对该季度的平均预期是每股收益 89 美分。华尔街预期为每股收益 88 美分至 92 美分。* Haemonetics 公司公布的本季度每股收益为 40 美分。* 公司报告的季度净收入为2037万美元。* Haemonetics Corp本季度股价上涨了9.3%,今年迄今为止上涨了9.1%。华尔街对 Haemonetics 公司 12 个月目标价的中位数为 105.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HAE","BK4198","IE00B64QTZ34.USD","LU1169590202.USD","LU1169589451.USD"],"gpt_icon":0},{"id":"2433722778","title":"Haemonetics Corp 预计每股收益89美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433722778","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433722778?lang=zh_cn&edition=full","pubTime":"2024-05-07 18:03","pubTimestamp":1715076181,"startTime":"0","endTime":"0","summary":" * Haemonetics Corp 将于5月9日公布截至2024年3月31日的财报,预计季度收入将有所增长。* 根据LSEG的数据,6位分析师的平均预期显示,这家总部位于波士顿马萨诸塞州的公司的营收将从去年同期的3.0442亿美元增至3.29113亿美元,增幅为8.1%。* LSEG 分析师对 Haemonetics 公司的平均预期为每股收益 89 美分。* 华尔街对 Haemonetics Corp 的 12 个月目标价中值为 105.00 美元,高于其上一交易日 95.38 美元的收盘价。5月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HAE"],"gpt_icon":0},{"id":"2426739480","title":"Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426739480","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426739480?lang=zh_cn&edition=full","pubTime":"2024-04-12 22:55","pubTimestamp":1712933721,"startTime":"0","endTime":"0","summary":"Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412225526876fb12b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412225526876fb12b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE"],"gpt_icon":0},{"id":"2417744763","title":"BUZZ-Haemonetics 因收购医疗设备制造商 Attune Medical 的交易而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2417744763","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417744763?lang=zh_cn&edition=full","pubTime":"2024-03-06 01:50","pubTimestamp":1709661044,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 3月5日 - ** 医疗保健公司Haemonetics 股价上涨1.8%至76.13美元 ** 该公司宣布 (link) 收购私营医疗设备制造商 Attune Medical 的最终协议 ** 作为交易的一部分,HAE将获得Attune的食道冷却设备ensoETM,该设备有助于减少手术过程中的食道损伤。** 根据交易,Co 将向 Attune 支付 1.6 亿美元的预付现金和未来的里程碑付款 ** 预计交易将于 2025 财年第一季度完成 - HAE** 包括盘中走势在内,该股在过去12个月下跌了1.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","HAE","IE00B64QTZ34.USD","LU1169590202.USD","BUZZ","BK4198"],"gpt_icon":0},{"id":"2415259968","title":"百度健康上线罕见病中心,法布雷病及HAE患者可开展线上自筛","url":"https://stock-news.laohu8.com/highlight/detail?id=2415259968","media":"美通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415259968?lang=zh_cn&edition=full","pubTime":"2024-02-29 16:11","pubTimestamp":1709194260,"startTime":"0","endTime":"0","summary":"由健康管理平台百度健康携手中国罕见病联盟共建的\"罕见病中心\"正式升级上线。在我国,法布雷病的总体筛查诊断率仅为3%。延迟诊断会增加HAE患者因喉部水肿发作导致的死亡风险。此次百度健康上线\"罕见病中心\"将为这些疾病提供科普和自筛指引,一方面提升大众对于法布雷病及HAE的疾病认知,另一方面帮助公众在面对疾病威胁时能够做到\"早筛查、早发现,早治疗\",从而提高诊断意识。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4349121_ZH49121_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4535","BK4077","BK4587","IE00B0JY6N72.USD","BK4552","IE00B64QTZ34.USD","LU0359202008.SGD","BK4588","BK4198","LU0287142896.SGD","LU0640798160.USD","BK4585","BK4526","BK4574","BK4504","BK4579","BK4514","LU0359201612.USD","LU1169590202.USD","BK4548","HAE","BK4007","TAK","LU1169589451.USD","BIDU","LU0173614495.USD","LU1023057109.AUD","LU1115378108.SGD","BK4531"],"gpt_icon":0},{"id":"2411355969","title":"更新版 1-KalVista 在遗传病后期试验中达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2411355969","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411355969?lang=zh_cn&edition=full","pubTime":"2024-02-13 20:10","pubTimestamp":1707826232,"startTime":"0","endTime":"0","summary":" 路透社2月13日 - KalVista Pharmaceuticals 周二称,其治疗一种遗传性疾病的疗法在一项后期试验中达到了主要目标,这种疾病会导致皮下和身体其他部位迅速肿胀。这种名为sebetralstat的疗法显示,遗传性血管性水肿 患者开始缓解症状的速度明显快于安慰剂。使用低剂量的sebetralstat,症状开始缓解的中位时间为1.61小时,而使用安慰剂则为6.72小时。Sebetralstat在136名成人和青少年HAE患者中进行了测试,HAE是一种因缺乏某种名为C1-抑制因子的蛋白质或其功能障碍而引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HAE","LU1169589451.USD","BK4198","KALV","IE00B64QTZ34.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2410050474","title":"美国血液技术盘中异动 股价大跌5.02%报74.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410050474","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410050474?lang=zh_cn&edition=full","pubTime":"2024-02-10 00:33","pubTimestamp":1707496395,"startTime":"0","endTime":"0","summary":"北京时间2024年02月10日00时33分,美国血液技术股票出现波动,股价急速下跌5.02%。截至发稿,该股报74.19美元/股,成交量19.1402万股,换手率0.38%,振幅5.32%。美国血液技术股票所在的医疗设备行业中,整体跌幅为0.13%。其相关个股中,Nanostring Technologies Inc、Stereotaxis Inc、Pulse Biosciences Inc涨幅较大,Nanostring Technologies Inc、Femasys Inc、Bionano Genomics Inc较为活跃,换手率分别为587.89%、1.79%、1.61%,振幅较大的相关个股有Nanostring Technologies Inc、中进医疗、Embecta Corporation,振幅分别为201.98%、46.53%、18.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021000331687e6fb4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021000331687e6fb4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HAE","IE00B64QTZ34.USD","LU1169589451.USD","BK4198","LU1169590202.USD"],"gpt_icon":0},{"id":"2409571740","title":"美国血液技术盘中异动 快速拉升5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409571740","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409571740?lang=zh_cn&edition=full","pubTime":"2024-02-08 22:34","pubTimestamp":1707402865,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日22时34分,美国血液技术股票出现波动,股价大幅上涨5.39%。截至发稿,该股报81.27美元/股,成交量1245股,换手率0.00%,振幅0.09%。美国血液技术股票所在的医疗设备行业中,整体跌幅为0.36%。其相关个股中,中进医疗、Femasys Inc、美国血液技术涨幅较大,Nanostring Technologies Inc、Femasys Inc、中进医疗较为活跃,换手率分别为6.39%、0.74%、0.31%,振幅较大的相关个股有中进医疗、Nanostring Technologies Inc、Femasys Inc,振幅分别为19.35%、12.97%、8.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223425877e0b09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223425877e0b09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169589451.USD","BK4198","LU1169590202.USD","HAE","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2409718264","title":"Haemonetics Corp 预计每股收益94美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2409718264","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409718264?lang=zh_cn&edition=full","pubTime":"2024-02-06 19:38","pubTimestamp":1707219537,"startTime":"0","endTime":"0","summary":" * Haemonetics Corp 将于2月8日公布截至2023年12月31日的财报,预计季度收入将有所增长。* 根据LSEG的数据,5位分析师的平均预期显示,这家总部位于波士顿马萨诸塞州的公司的营收将从去年同期的3.053亿美元增至3.2029亿美元,增幅为4.9%。* LSEG 分析师对 Haemonetics 公司的平均预期为每股收益 94 美分。* 华尔街对 Haemonetics Corp 的 12 个月目标价中位数为 105.00 美元,高于上一交易日的收盘价 75.38 美元。2月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HAE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.haemonetics.com","stockEarnings":[{"period":"1week","weight":0.027},{"period":"1month","weight":-0.0438},{"period":"3month","weight":0.0037},{"period":"6month","weight":0.0434},{"period":"1year","weight":0.0291},{"period":"ytd","weight":-0.0064}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0698},{"period":"6month","weight":0.1853},{"period":"1year","weight":0.2615},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Haemonetics Corporation成立于1971年,是一个全球性医疗设备公司,致力于为客户提供创新的血液管理解决方案——血浆来源收集者,采血机构和医院,在输血行业医疗设备系统方面有着强大的品牌优势,为客户提供解决方案的同时还提供信息技术平台和增值服务,其解决方案帮助患者改善临床结果,并提高血液中的供应链效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.01405},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.011877},{"month":3,"riseRate":0.69697,"avgChangeRate":0.022898},{"month":4,"riseRate":0.484848,"avgChangeRate":-0.025124},{"month":5,"riseRate":0.515152,"avgChangeRate":0.015931},{"month":6,"riseRate":0.588235,"avgChangeRate":0.019344},{"month":7,"riseRate":0.676471,"avgChangeRate":0.016991},{"month":8,"riseRate":0.757576,"avgChangeRate":0.035488},{"month":9,"riseRate":0.515152,"avgChangeRate":0.015262},{"month":10,"riseRate":0.515152,"avgChangeRate":-0.002825},{"month":11,"riseRate":0.515152,"avgChangeRate":0.023869},{"month":12,"riseRate":0.606061,"avgChangeRate":0.028114}],"exchange":"NYSE","name":"美国血液技术","nameEN":"Haemonetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美国血液技术,HAE,美国血液技术股票,美国血液技术股票老虎,美国血液技术股票老虎国际,美国血液技术行情,美国血液技术股票行情,美国血液技术股价,美国血液技术股市,美国血液技术股票价格,美国血液技术股票交易,美国血液技术股票购买,美国血液技术股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}